This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Haemonetics (HAE) Buys enicor to Expand Testing Portfolio
by Zacks Equity Research
Haemonetics (HAE) expands its portfolio with the buyout of enicor. With the latter's whole blood coagulation testing system, the company will address a wider range of criticalities in medicine.
Here's Why You Should Retain AMN Healthcare (AMN) for Now
by Zacks Equity Research
Investor confidence remains high on AMN Healthcare's (AMN) stock, thanks to solid prospects.
Align Technology Buys exocad to Expand Its Digital Platform
by Zacks Equity Research
Align Technology (ALGN) expands its portfolio with the buyout completion of exocad. This will help the company offer fully integrated workflows to dental labs and dental practices worldwide.
IDEXX's (IDXX) CAG Arm Grows Strong on Product Launches
by Zacks Equity Research
Product launches like Cornerstone, Neo, Animana aid IDEXX' (IDXX) CAG business.
Walgreens Boots (WBA) Q2 Earnings Top Estimates, Margins Down
by Zacks Equity Research
The coronavirus outbreak had an immaterial impact on Walgreens Boots' (WBA) second-quarter fiscal 2020 results.
Here's Why You Should Hold on to Teleflex (TFX) Stock Now
by Zacks Equity Research
Investors continue to be optimistic about Teleflex (TFX) on its strong segmental and international growth in the fourth quarter of 2019.
Here's Why You Should Add Surmodics to Your Portfolio Now
by Zacks Equity Research
Investor confidence is high in Surmodics' (SRDX) stock,thanks to solid prospects.
3 Must-Buy Stocks as Coronavirus Cases Spike (Revised)
by Zacks Equity Research
COVID-19 has increased the demand for ventilators and personal protective equipment, which can aid these three companies at large.
Varian Unveils Proton Treatment Planning Eclipse v16 System
by Zacks Equity Research
The launch of this system is a step forward in Varian's (VAR) commitment toward strengthening its Proton Solutions segment.
Bruker (BRKR) Q4 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Bruker's (BRKR) fourth-quarter 2019 results reflect strong performances by the majority of its segments and geographies.
The Zacks Analyst Blog Highlights: General Motors, Tesla, Cardinal Health, ResMed and Medtronic
by Zacks Equity Research
The Zacks Analyst Blog Highlights: General Motors, Tesla, Cardinal Health, ResMed and Medtronic
Abbott (ABT) Rides on Point-of-Care Coronavirus Test Launch
by Zacks Equity Research
Abbott (ABT) launches a portable molecular point-of-care test to speed up coronavirus detection, especially in areas with severe outbreaks.
Here's Why You Should Hold on to Abbott (ABT) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about Abbott (ABT) on its strong segmental results in the fourth quarter of 2019.
STERIS' (STE) Organic Growth Robust Amid Bottom-Line Hurdles
by Zacks Equity Research
STERIS (STE) continues to register stellar organic growth across all four operating segments.
Here's Why You Should Add DexCom (DXCM) to Your Portfolio Now
by Zacks Equity Research
Investor confidence is high in DexCom's (DXCM) stock, thanks to solid prospects.
Medtronic's Evolut TAVR System Shows Positive Study Results
by Zacks Equity Research
Medtronic (MDT) presents favorable study outcomes for its Evolut TAVR system, which is expected to offer better treatment options to low-risk bicuspid aortic valve stenosis patients.
4 MedTech Stocks Set to Rebound Post Coronavirus-Led Crisis
by Zacks Equity Research
Here are some MedTech stocks which are steadily inching toward a trend reversal after registering record declines over the past few weeks.
Syneos Health Launches Initiative for COVID-19 Patients
by Zacks Equity Research
The primary aim of this initiative by Syneos Health (SYNH) is to address the predicted ventilator deficiency in the wake of the coronavirus pandemic.
3 Must-Buy Stocks as Coronavirus Cases Spike
by Zacks Equity Research
COVID-19 has increased the demand for ventilators and personal protective equipment, which can aid these three companies at large.
New Buyouts Aid Boston Scientific Amid Coronavirus Crisis
by Zacks Equity Research
The current economic turbulence due to the coronavirus outbreak is massively causing depreciation of Boston Scientific's (BSX) stock.
Here's Why You Should Hold on to LabCorp (LH) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about LabCorp (LH) on its strong segmental results in the fourth quarter of 2019.
QIAGEN Releases Coronavirus Test Kit in US on New FDA Policy
by Zacks Equity Research
QIAGEN (QGEN) releases test kits in the United States to speed up the diagnosis of coronavirus per the FDA's latest policy.
Stellar Codman Surgical Sales Aid Integra Amid Supply Issues
by Zacks Equity Research
Completion of integration activities, scale expansion, product launches, and venturing into faster-growing markets drive Interga's (IART) sales within Codman Surgical.
New Buyouts & Envigo Deal Aid LabCorp Amid Regulatory Woes
by Zacks Equity Research
LabCorp's (LH) Covance arm grows on strategic acquisitions including MI Bioresearch.
Here's Why You Should Hold on to Insulet (PODD) Stock Now
by Zacks Equity Research
Investors remain confident in Insulet (PODD) stock on solid prospects.